BioMarin acquiring Alesta Therapeutics for $275 million

Keyword: Pharmacokinetics

Publisher: Quartz India

Published: Aug 19, 2026

BioMarin Pharmaceutical announced Tuesday it has entered into a definitive agreement to acquire Alesta Therapeutics for $275 million upfront, plus up to $215 million in additional payments tied to de… [+2521 chars]

Read Full Story ↗